Takeda Selects Five New Partnerships for Globae's Annual Corporate Social Responsibility (CSR) Program to Support Disease Prevention and Improved Health in Developing and Transition Countries

  • Takeda's founding mission, which is to serve patients wherever they are, is the engine of choice its commitment to working with the global community on disease prevention, capacity building and access to health care in developing and emerging countries use.
  • As part of the annual Global CSR program, approximately 20,000 employees worldwide voted in favor of the City Cancer Challenge, the Neglected Diseases Drug Program (DNDi), the SeriousFun Network for Children, UNICEF and of the United Nations Foundation in 2019.
  • Through these programs, Takeda has contributed a total of 10.5 billion yen to its 14 programs since its launch in 2016 through its unique Global CSR program.

Takeda Pharmaceutical Company Limited (TAKEO: 4502 / NYSE: TAK) ("Takeda") today announced the addition of five partners to its global CSR program for 2019, which will contribute to long-term health population through disease prevention and capacity building in developing and transition countries. contributes. Around 20,000 employees worldwide voted and selected five new large-scale programs as part of the City Cancer Challenge, the drug for neglected diseases. initiative (DNDI), the SeriousFun Children's Network, UNICEF and the United Nations Foundation. The five programs will be launched by the aforementioned organizations in partnership with Takeda. This year, Takeda has increased its commitment to 4.6 billion yen to accelerate change and tackle some of the biggest challenges in the world.

Takeda's global CSR program, its flagship CSR activity, makes multi-year commitments in partnership with key global stakeholders. The program is patient-based and the company's commitment to disease prevention and access to health care, which is changing the lives of people in developing countries and countries emerging. Since their launch in 2016, partnerships within the global CSR agenda have produced tangible results and are a major component of efforts to achieve the Global Sustainable Development Goals (SDGs). * Results range from broadening patient access to high-quality diagnosis and treatment, including vaccination, in countries where the disease has developed, training health workers and strengthening health systems worldwide.

"We look forward to helping change the lives of the best and working closely with these creative and influential organizations to accelerate progress towards the SDGs," said Haruhiko Hirate, Communications and Public Affairs Manager. . "We know that long-term commitments are important, and we currently have nine programs running between three and ten years, each program is carefully selected by the employees in the 80 countries we operate in. It is very important to all of us that Takeda contributes to the health of people in communities around the world. "

As a pharmaceutical company dedicated to improving human lives, Takeda's vision for innovation in healthcare and future more promising for people around the world is fueled by the main innovations in medicine. His vision is a world of accessible health care, where prevention is exponentially conducted and billions of diseases are being eliminated. Takeda strives to achieve the SDGs with the global community.

In addition to the following 14 programs, Takeda also supports public-private partnerships to improve health with the Japanese government around the world, such as: The Global Fund for Innovative Health Technologies (GHIT) and the Coalition for Innovations epidemic preparedness (CEPI), the Global Fund to Fight AIDS, Tuberculosis and Malaria).

Overview of the Program and Partner Organizations for the 2019 Fiscal Year

partner

description of the program

zoned

period

Budget (Yen)

1

SeriousFun Children's Network

Changing the lives of critically ill children and their families

United States, Europe, Africa, Asia and the Caribbean

5 years

1 billion

2

DNDI

Global access program for the most neglected patients

16 countries of Africa, Asia and South America

5 years

1 billion

3

City Cancer Challenge

City health financing laboratory

at the World level

5 years

1 billion

4

United Nations Foundation

Vaccination and universal health care

Sub-Saharan Africa *

5 years

550 million

5

UNICEF

Invest in innovation and advanced technology

at the World level

5 years

1 billion

The following nine programs, selected by Takeda employees in 2016, 2017 and 2018, are progressing well.

Overview of the Program and Partner Organizations for the 2018 Fiscal Year

partner

description of the program

zoned

period

Budget (Yen)

1

Last mile health

A health worker for everyone, everywhere, anytime

at the World level

3 years

400 million

2

Seed Global Health

Training of 5,000 health professionals in sub-Saharan Africa

Sub-Saharan Africa *

5 years

500 million

3

UNICEF

Strengthening the health system in sub-Saharan Africa

Angola, Guinea and Togo

5 years

500 million

Program Outlines and Partner Organizations for FY 2017

partner

description of the program

zoned

period

Budget (Yen)

1

UNICEF

"The first 1000 days": health and nutrition program

Benin, Madagascar and Rwanda

5 years

1 billion

2

International Plan

Global Support Program for Refugees from South Sudan and Syria

Egypt, Jordan, Lebanon, South Sudan, Sudan, Uganda and Ethiopia

5 years

1 billion

3

JOICFP

Protecting the lives of pregnant women in Africa

Ghana, Tanzania, Kenya and Zambia

5 years

750 million

Program Insights and Partner Organizations for FY 2016

partner

description of the program

zoned

period

Budget (Yen)

1

United Nations Foundation

Global measles vaccine in children

About 40 countries from Africa, Asia and Latin America

10 years

1 billion

2

World Vision

Train community health workers in the health of mothers and children

India, Bangladesh, Nepal and Afghanistan

5 years

500 million

3

Save the children

Maternal and neonatal health among ethnic minorities

Myanmar, Vietnam and Laos

5 years

250 million

* Sustainable Development Goals (SDGs): On 25 September 2015, the United Nations adopted a set of 17 targets under the 2030 Agenda for Sustainable Development, including 169 Sustainable Development Goals.

Partner organizations and program descriptions

1. SeriousFun Children's Network: The lives of critically ill children and their families

Overview: This program aims to develop and develop innovative new programs for the global network of specialized medical camps and programs that enable children with serious illnesses and their families to live life-transforming experiences. Conduct research and evaluation efforts to monitor the impact of the camp on the lives of children and families and to improve programs to meet their needs; and build medical capacity across the network.

– Regions: United States, Europe, Africa, Asia and the Caribbean

– Period: 5 years

– Budget: 1 billion yen

2. DNDi: global access program for the most neglected patients

– Description: This program aims to increase the access of neglected patients to high quality diagnosis and treatment in pathogenic countries, including those in peripheral areas, to prevent disease progression while saving lives. DNDIfocuses on five neglected tropical diseases (neglected tropical diseases): sleeping sickness, Chagas disease, leishmaniasis, onchocerciasis and mycetoma, characterized by significant morbidity and / or mortality and due to availability and accessibility currently limited diagnosis and effective treatment were prioritized:

– Regions: 16 countries of Africa, Asia and South America

– Period: 5 years

– Budget: 1 billion yen

3. City Cancer Challenge: City Health Finance Lab

– Overview: The City Cancer Challenge's participatory and inclusive approach involves the private sector, civil society and governments to improve the quality of cancer care and treatment and strengthen health systems. By supporting 10 cities in the development, planning and implementation of sustainable cancer solutions, City Cancer Challenge will reach about 80 million people by 2023.

– Regions: Global

– Period: 5 years

– Budget: 1 billion yen

4. United Nations Foundation: Immunization and universal health care

– Summary: Takeda's partnership with Shot @ Life aims to strengthen health systems in sub-Saharan Africa through improved disease surveillance and data retrieval, enabling effective vaccination planning and response. More effective immunization programs will reach more children, strengthen primary health care and bring these countries closer to overall health care

– Regions: Sub-Saharan Africa

– Period: 5 years

– Budget: 550 million yen

5. UNICEF: investing in innovation and advanced technologies

– Overview: This program will invest in health care and drone start-ups to develop, implement and adapt innovative child-based solutions, as well as large-scale epidemiological modeling based on intelligence artificially to predict epidemics of infectious diseases in three countries. and to prevent:

– Regions: Global

– Period: 5 years

– Budget: 1 billion yen

About the SeriousFun children's network

The SeriousFun Children's Network is a global community of 30 camps and programs that help children with serious illnesses and their families, always for free. The network is at the forefront of specialized medical camps, providing more than one million life-changing experiences for children and families in more than 50 countries. Each member camp is an independent, non-profit organization that relies on private funds to serve all children at no cost to their families. For more information on SeriousFun, visit www.seriousfunnetwork.org.

About DNDi

DND is a non-profit research and development organizationI develop new treatments for neglected diseases such as leishmaniasis, filarial infections, African sleeping sickness, Chagas disease and mycetoma, as well as for neglected patients, including pediatric patients with HIV and people living with the hepatitis C virus, and unable to access it because of high costs Have a treatment to offer. DNDI developed eight new treatments, including new drug combinations for visceral leishmaniasis, two fixed-dose antimalarials, and DNDIThe first successfully developed chemical, fexinidazole, was approved in 2018 for the treatment of both phases of sleeping sickness. www.dndi.org

About the City Cancer Challenge

City Cancer Challenge's mission is to create a global community of cities and partners working together to develop, plan and implement life-saving cancer solutions. Our goal is to improve access to quality cancer care in countries around the world by changing how local, regional, and national stakeholders work together to design, plan, and implement solutions. local cancer control. The approach is based on the premise that cities can strengthen their impact at the national level by developing data-driven solutions with the support of a network of global, regional and local partners reflecting an understanding of the local context. unique. https://citycancerchallenge.org/

About the United Nations Foundation

In our interconnected world, our common future rests on our ability to work together for a common purpose. The United Nations was created to strengthen international cooperation in the service of common interests and values. It is the only place where all countries and all citizens can come together to meet our greatest challenges and create a better world for all. The United Nations Foundation supports the ability of the United Nations to meet these challenges and seize opportunities for the benefit of all humankind. At the dawn of the 21st century, this task is more urgent than ever. We work by building communities and establishing initiatives to support the UN and its priority themes, including the achievement of the Sustainable Development Goals (SDGs). https://shotatlife.org/

About UNICEF

UNICEF works in the most difficult places in the world to reach the world's most disadvantaged children. In more than 190 countries, we work for every child, every place, to build a better world for all.

Follow UNICEF twitter and Facebook

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TOKYO: 4502 / NYSE: TAK) is a leading, value-based biopharmaceutical research group based in Japan. He believes that his mission is to help patients improve their health and ensure a more positive future by obtaining highly innovative medicines from scientific research. Takeda's research and development efforts focus on four therapeutic areas: oncology, gastroenterology (GI), rare diseases and neuroscience. We also invest targeted portions of our research budget in plasma drug and vaccine therapies. We focus on the development of highly innovative medicines that help to effectively improve people's quality of life. To do this, we are opening up new processing options and leveraging our enhanced and synergistic research area and our common capabilities to create a robust, multimodal pipeline. Our employees are committed to improving the quality of life for patients and work with our health partners in approximately 80 countries and regions.

Please visit https://www.takeda.com for more information

The source language in which the original text is published is the official and authorized version. Translations are provided for better understanding. Only the language version published in the original is legal. Compare the translations with the original language version of the publication.

Check out the original version on businesswire.com: https://www.businesswire.com/news/home/20190628005552/en/

Press contact:

Takeda Pharmaceutical Company Limited

Kazumi Kobayashi

kazumi.kobayashi@takeda.com

+81 (0) 3 3278 2095